NovaBridge Biosciences (NBP) Cash from Investing Activities (2019 - 2025)

NovaBridge Biosciences (NBP) reported Cash from Investing Activities of $105.0 million for Q4 2025, up 1176.84% quarter-over-quarter from $8.2 million in Q4 2020.

NovaBridge Biosciences (NBP) Cash from Investing Activities (2019 - 2025) Analysis & Trends

NovaBridge Biosciences (NBP) has 3 years of Cash from Investing Activities data on file, last reported at $105.0 million in Q4 2025.

  • Cash from Investing Activities for Q4 2025 came in at $105.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $105.0 million (up 416.1% YoY), and the FY2025 annual result was $105.0 million, up 570.93% from the prior year.
  • Cash from Investing Activities improved to $105.0 million in Q4 2025 per NBP's latest filing, from $8.2 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $105.0 million in Q4 2025 and troughed at $105.0 million in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -2.89 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -431.90 Mn
9 Abivax 90.15 Bn 90.15 Bn - 579,519.10
10 NovaBridge Biosciences 328.19 Mn 117.34 Mn - 104.97 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 104.97 Mn
Dec 31, 2025 104.97 Mn
Dec 31, 2020 8.22 Mn
Dec 31, 2020 8.22 Mn
Sep 30, 2020 -41.43 Mn
Sep 30, 2020 -41.43 Mn
Dec 31, 2019 10.97 Mn
Dec 31, 2019 10.97 Mn